TABLE II.
PR (n = 405) | RI-PR (n = 112) | RI-DR (n = 137) | RI white (n = 151) | Post hoc comparisons | |
---|---|---|---|---|---|
Inhaled steroid use (%) | 15 | 48 | 34 | 50 | PR < RI-DR < RI-PR, RI white* |
Any controller medication (%) | 32 | 65 | 63 | 68 | PR < RI-PR RI-DR, RI white* |
PR, Puerto Rican; RI-PR, RI Puerto Rican; RI-DR, RI Dominican; NS, not significant.
P < .001.